GENEPOSSIBILITIES.COM

Serial Number 97232135
602

Registration Progress

Application Filed
Jan 21, 2022
Under Examination
Jan 10, 2023
Approved for Publication
Nov 15, 2022
Published for Opposition
Nov 15, 2022
Registered

Trademark Image

GENEPOSSIBILITIES.COM

Basic Information

Serial Number
97232135
Filing Date
January 21, 2022
Published for Opposition
November 15, 2022
Abandonment Date
June 30, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 17, 2023
Classes
042 044

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
50 Northern Avenue
Boston, MA 02210

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Boston, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

24 events
Date Code Type Description Documents
Jul 17, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jul 17, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jul 17, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Mar 29, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Mar 29, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 13, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 13, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 13, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 13, 2023 IUAF S USE AMENDMENT FILED Loading...
Jan 10, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 7, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 15, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 14, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 8, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of gene editing
First Use Anywhere: May 5, 2022
First Use in Commerce: May 5, 2022
Class 044
Providing medical and healthcare information in the field of gene editing technology; Providing medical and healthcare information in the field of gene editing technology to health care professionals, to persons having genetic diseases, and to their caregivers
First Use Anywhere: May 5, 2022
First Use in Commerce: May 5, 2022

Additional Information

Pseudo Mark
GENE POSSIBILITIES

Classification

International Classes
042 044